[Losartan, new angiotensin receptor antagonist--a challenge for enzyme converting angiotensin inhibitors?].
Chabielska
E
E
Zakład Farmakokinetyki Ak. Med., Białymstoku.
Pawlak
R
R
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D019808:Losartan / Q000494:pharmacology* / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D019808:Losartan
Losartan, nowy antagonista receptora angiotensynowego--wyzwanie dla inhibitorów konwertazy angiotensyny?